Li Min, Zhou Ming, Wen Peng, Wang Qiang, Yang Yong, Xiao Hu, Xie Zhengyuan, Li Xing, Wang Ning, Wang Jinyan, Luo Fei, Chang Jingyu, Zhang Wangming
The National Key Clinic Specialty, The Engineering Technology Research Center of Education Ministry of China, Guangdong Provincial Key Laboratory on Brain Function Repair and Regeneration, Department of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China.
Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Exp Neurol. 2016 Aug;282:27-36. doi: 10.1016/j.expneurol.2016.05.007. Epub 2016 May 6.
Oscillatory activity has been well-studied in many structures within cortico-basal ganglia circuits, but it is not well understood within the pedunculopontine nucleus (PPN), which was recently introduced as a potential target for the treatment of gait and postural impairments in advanced stages of Parkinson's disease (PD). To investigate oscillatory activity in the PPN and its relationship with oscillatory activity in cortico-basal ganglia circuits, we simultaneously recorded local field potentials in the PPN, primary motor cortex (M1), and subthalamic nucleus (STN) of 6-hydroxydopamine (6-OHDA)-induced hemiparkinsonian rats during resting and walking. After analysis of power spectral density, coherence, and partial Granger causality, three major findings emerged: 1) after 6-OHDA lesions, beta band oscillations were enhanced in all three regions during walking; 2) the direction of information flow for beta oscillations among the three structures was STN→M1, STN→PPN, and PPN→M1; 3) after the treatment of levodopa, beta activity in the three regions was reduced significantly and the flow of beta band was also abrogated. Our results suggest that beta activity in the PPN is transmitted from the basal ganglia and probably comes from the STN, and the STN plays a dominant role in the network of causal interactions for beta activity. Thus, the STN may be a potential source of aberrant beta band oscillations in PD. Levodopa can inhibit beta activity in the PPN of parkinsonian rats but cannot relieve parkinsonian patients' axial symptoms clinically. Therefore, beta oscillations may not be the major cause of axial symptoms.
振荡活动在皮质-基底神经节回路的许多结构中已得到充分研究,但在脚桥核(PPN)中却了解甚少,而PPN最近被认为是治疗帕金森病(PD)晚期步态和姿势障碍的潜在靶点。为了研究PPN中的振荡活动及其与皮质-基底神经节回路中振荡活动的关系,我们在静息和行走期间同时记录了6-羟基多巴胺(6-OHDA)诱导的偏侧帕金森病大鼠的PPN、初级运动皮层(M1)和丘脑底核(STN)的局部场电位。在分析功率谱密度相干性和部分格兰杰因果关系后,出现了三个主要发现:1)6-OHDA损伤后,行走期间所有三个区域的β波段振荡均增强;2)三个结构之间β振荡的信息流方向为STN→M1、STN→PPN和PPN→M1;3)左旋多巴治疗后,三个区域的β活动显著降低,β波段的流动也被消除。我们的结果表明,PPN中的β活动从基底神经节传递而来,可能来自STN,并且STN在β活动的因果相互作用网络中起主导作用。因此,STN可能是PD中异常β波段振荡的潜在来源。左旋多巴可以抑制帕金森病大鼠PPN中的β活动,但在临床上不能缓解帕金森病患者的轴性症状。因此,β振荡可能不是轴性症状的主要原因。